Literature DB >> 1660025

Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.

S Nishiguchi1, T Kuroki, T Yabusako, S Seki, K Kobayashi, T Monna, S Otani, M Sakurai, T Shikata, S Yamamoto.   

Abstract

The relationship between alcoholic liver disease and hepatitis C virus was studied in 80 patients by searching for hepatitis C virus RNA with the polymerase chain reaction and by measuring hepatitis C virus antibodies. By C-100 enzyme-linked immunosorbent assay, hepatitis C virus antibodies were found in 2 of 10 patients with fibrosteatosis, 8 of 20 patients with alcoholic hepatitis, 14 of 19 patients with chronic hepatitis and 19 of 31 patients with cirrhosis. Percentages of patients with antibodies found by C-100 radioimmunoassay and by enzyme-linked immunosorbent assay based on sequence peptide 42 were lower; of the 16 patients with a low titer by C-100 enzyme-linked immunosorbent assay, 10 were negative by radioimmunoassay and 6 were negative by sequence peptide 42. By a second-generation recombinant immunoblot assay, hepatitis C virus antibodies were found in 1 of 10 patients with fibrosteatosis, 2 of 20 patients with alcoholic hepatitis, 15 of 19 patients with chronic hepatitis and 18 of 31 patients with cirrhosis. Hepatitis C virus RNA was found in 1 of 10 patients with fibrosteatosis, 3 of 20 patients with alcoholic hepatitis, 13 of 19 patients with chronic hepatitis and 20 of 31 patients with cirrhosis. Of the 37 patients with hepatitis C virus RNA, 31 had antibodies by C-100 enzyme-linked immunosorbent assay (25 patients at a high titer [cut-off index greater than 6]), and 31 had antibodies by second-generation recombinant immunoblot assay. Patients with cirrhosis and hepatitis C virus RNA had higher ALT activity than such patients without hepatitis C virus RNA (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660025

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.

Authors:  S Anderson; C L Nevins; L K Green; H El-Zimaity; B S Anand
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 3.  Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?

Authors:  Donna M Evon; Carol E Golin; Michael W Fried; Francis J Keefe
Journal:  J Consult Clin Psychol       Date:  2012-06-25

4.  Liver transplantation in patients with chronic hepatitis C and alcoholism.

Authors:  S Dhar; L Omran; B R Bacon; H Solomon; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

Review 5.  Alcoholic hepatitis and HCV interactions in the modulation of liver disease.

Authors:  C S Punzalan; T N Bukong; G Szabo
Journal:  J Viral Hepat       Date:  2015-03-06       Impact factor: 3.728

6.  Interaction of alcohol and hepatitis C virus infection on severity of liver disease.

Authors:  C L Nevins; H Malaty; M E Velez; B S Anand
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

Review 7.  Alcoholic hepatitis and concomitant hepatitis C virus infection.

Authors:  Mohamed Shoreibah; Bhupinderjit S Anand; Ashwani K Singal
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 8.  Hepatitis C virus and alcohol.

Authors:  Larry Siu; Julie Foont; Jack R Wands
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

9.  Hepatitis B and C markers among alcoholics in Israel: high incidence of HCV infection.

Authors:  I Srugo; E Shinar; S Bar-Shany; L Amos
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

10.  Prevalence of problem alcohol use among patients attending primary care for methadone treatment.

Authors:  Niamh Ryder; Walter Cullen; Joseph Barry; Gerard Bury; Eamon Keenan; Bobby P Smyth
Journal:  BMC Fam Pract       Date:  2009-06-11       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.